Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Cantor Fitzgerald
Mallinckrodt
Boehringer Ingelheim
Fish and Richardson
Merck
Covington
Healthtrust
McKesson

Generated: February 21, 2018

DrugPatentWatch Database Preview

FULVICIN P/G 165 Drug Profile

« Back to Dashboard

When do Fulvicin P/g 165 patents expire, and when can generic versions of Fulvicin P/g 165 launch?

Fulvicin P/g 165 is a drug marketed by Chartwell Rx and is included in one NDA.

The generic ingredient in FULVICIN P/G 165 is griseofulvin, ultramicrocrystalline. There is one drug master file entry for this compound. Additional details are available on the griseofulvin, ultramicrocrystalline profile page.
Summary for FULVICIN P/G 165
Drug patent expirations by year for FULVICIN P/G 165

US Patents and Regulatory Information for FULVICIN P/G 165

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx FULVICIN P/G 165 griseofulvin, ultramicrocrystalline TABLET;ORAL 061996-003 Apr 6, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cipla
Federal Trade Commission
US Army
Accenture
UBS
Queensland Health
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot